Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Microvision CEO Sumit Sharma expresses heightened confidence in the company's competitive position in the lidar technology market.
00:10:00
Michael Mandelbaum on the Future of the Russia-Ukraine War|Michael Mandelbaum,Professor,Johns Hopkins University
00:10:00
Joe Sachetta discusses insights and experiences from Sachetta & Callahan.
00:10:00
Investing in CY4GATE Stocks: Insights with CEO Emanuele Galtieri and CFO Marco Latini | Emanuele Galtieri, CEO, CY4Gate SpA.
00:10:00
David Hampstead on Samarkand Group's Contract Extension with TEMPLESPA and New Distribution Agreements in China | David Hampstead, CEO , Samarkand Global PLC.
00:10:00
DOKTA (Döktaş Foundry Trade and Industry Inc.) | Tevfik YAMANTÜRK - Chairman of Componenta Dokumculuk Ticaret ve Sanayi AS
00:10:00
Invests in idea-stage founders who has assembled a team|Binh Tran,General Partner,Ascend Vietnam Ventures
00:10:00
Highlights from NAHB International Builders' Show 2024: Celebrating Hardie® Products & Company Initiatives! | AARON ERTER - CEO of James Hardie Industries PLC.
00:10:00
Keynote Address: Peter Orszag on Economic Policy and Advisory Insights | Peter Orszag - Chief Executive Officer at Lazard Asset Management
00:10:00
The Miami Opportunity Expanding Access and Advancing Equity|Nico Berardi,Founder and General Partner,ANIMO Ventures
00:10:00
Nickel, Copper, and Gold Exploration Projects in Africa and Australia
00:10:00
Private Market Valuations and Capital Flows at PE Firms | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.

© 2017 - Neuhu+